Thanks for posting this, GMT2.
Well - that was a super confident Leslie. She clearly expects great things from Azer-Cel - which is entirely reasonable given the results of the Phase 1 trial - but her eyes really light up when it comes to CF33. And that's understandable too - given the early data from the MAST trial, and the enormous breadth of the potential application across many/most solid tumour types, both in the Vaxinia form and through OnCARlytics.
"We will continue, hopefully, to get great news off of the MAST study ..."
"I have to say that the oncolytic viral therapies, as well as Azer-Cel, are... are behaving ...quite nicely."
Cheers
Dave
Thanks for posting this, GMT2.Well - that was a super confident...
-
- There are more pages in this discussion • 4,449 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $51.52K | 977.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 2243456 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1573817 | 20 |
View Market Depth
| Last trade - 11.56am 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |